Paul Tudor Jones Uro Gen Pharma Ltd. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$14.31 - $18.39 $358,436 - $460,632
-25,048 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$15.2 - $20.94 $380,729 - $524,505
25,048 New
25,048 $382,000
Q2 2019

Aug 14, 2019
SELL
$32.75 - $40.35 $204,196 - $251,582
-6,235 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$35.47 - $54.55 $221,155 - $340,119
6,235 New
6,235 $230,000

Others Institutions Holding URGN

# of Institutions
130
Shares Held
35.9M
Call Options Held
22K
Put Options Held
93.8K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $274M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email